Trial Profile
Terapia Con Everolimus Nel Trapianto de Novo di Fegato: Uno Studio Multicentrico Randomizzato [Everolimus Therapy in Liver Novo Transplantation: a Randomized Multicenter Study]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Basiliximab; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms EPOCAL
- 28 Dec 2018 Results asssessing very early introduction of everolimus in de novo liver transplantation, published in the Liver Transplantation
- 16 Sep 2015 Status changed from recruiting to completed, according to an abstract presented at the 17th Congress of the European Society for Organ Transplantation.
- 16 Sep 2015 Primary endpoint has been met. (Biopsy-proven rejection episodes (BPAR)), according to an abstract at the 17th Congress of the European Society for Organ Transplantation.